Nadolol and Bendroflumethiazide is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Impax Generics. The primary component is Nadolol; Bendroflumethiazide.
| Product ID | 0115-5311_2669933a-33f4-478a-bd9d-9fe48429bcc9 |
| NDC | 0115-5311 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Nadolol and Bendroflumethiazide |
| Generic Name | Nadolol And Bendroflumethiazide |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2007-03-30 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA077833 |
| Labeler Name | Impax Generics |
| Substance Name | NADOLOL; BENDROFLUMETHIAZIDE |
| Active Ingredient Strength | 40 mg/1; mg/1 |
| Pharm Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2007-03-30 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA077833 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2007-03-30 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA077833 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2007-03-30 |
| Inactivation Date | 2020-01-31 |
| Ingredient | Strength |
|---|---|
| NADOLOL | 40 mg/1 |
| SPL SET ID: | d2d226ea-1624-47ee-82bf-e9660b75029f |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0115-5311 | Nadolol and Bendroflumethiazide | NADOLOL and BENDROFLUMETHIAZIDE |
| 0115-5322 | Nadolol and Bendroflumethiazide | NADOLOL and BENDROFLUMETHIAZIDE |
| 60793-283 | CORZIDE | nadolol and bendroflumethiazide |
| 60793-284 | CORZIDE | nadolol and bendroflumethiazide |